TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Safety and efficacy of combination immunotherapy with interferon alfa-2b and tremelimumab in patients with stage IV melanoma.

Ahmad A Tarhini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.